Earnings History Data for Amicus Therapeutics, Inc. (FOLD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amicus Therapeutics, Inc.

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-05-2022 PM 7:00 AM ET
(May 9)
FOLD Amicus Therapeutics, Inc. 1,850 -0.30 -0.24 -0.25 Amicus Therapeutics GAAP EPS of -$0.30 misses by $0.04, revenue of $78.7M beats by $1.56M; updates FY22 guidance
[5/9/2022 7:03 AM]
6.20 -0.07 
(-1.20%)
6.46 0.19 
(3.03%)
5.91 - 12.63 8,432,714 4,470,000 502
24-02-2022 PM 7:00 AM ET
(Feb 24)
FOLD Amicus Therapeutics, Inc. 2,420 -0.29 -0.14 -0.27 Amicus Therapeutics GAAP EPS of -$0.92 misses by $0.16, revenue of $305.51M misses by $1.21M
[2/24/2022 7:03 AM]
8.92 -0.34 
(-3.67%)
0.0 0.0 
(0.00%)
8.40 - 20.15 738,794 2,586,816 0
09-11-2021 PM 7:00 AM ET
(Nov 9)
FOLD Amicus Therapeutics, Inc. 3,330 -0.19 -0.18 -0.22 Amicus Therapeutics EPS misses by $0.02, misses on revenue
[11/9/2021 7:02 AM]
11.34 -0.59 
(-4.95%)
11.73 -0.20 
(-1.68%)
8.60 - 25.39 1,427,395 2,320,000 106,400
05-08-2021 PM 7:00 AM ET
(Aug 5)
FOLD Amicus Therapeutics, Inc. 2,470 -0.19 -0.21 -0.20 Amicus Therapeutics EPS beats by $0.02, beats on revenue
[8/5/2021 7:07 AM]
10.06 0.39 
(3.98%)
9.85 0.17 
(1.76%)
8.60 - 25.39 1,840,505 2,300,000 41,135
10-05-2021 PM 7:00 AM ET
(May 10)
FOLD Amicus Therapeutics, Inc. 2,740 -0.25 -0.23 -0.35 Amicus Therapeutics EPS misses by $0.01, misses on revenue
[5/10/2021 7:04 AM]
9.39 -0.36 
(-3.69%)
9.81 0.06 
(0.62%)
8.83 - 25.39 1,759,098 2,330,000 91,660
01-03-2021 PM 7:00 AM ET
(Mar 1)
FOLD Amicus Therapeutics, Inc. 3,180 -0.27 -0.21 -0.35 Amicus Therapeutics EPS misses by $0.08, beats on revenue
[3/1/2021 7:06 AM]
11.76 -0.52 
(-4.19%)
12.40 0.12 
(0.98%)
6.25 - 25.39 5,041,692 8,852,331 32,376
05-11-2020 PM 7:00 AM ET
(Nov 5)
FOLD Amicus Therapeutics, Inc. 4,910 -0.22 -0.20 -0.24 Amicus Therapeutics EPS misses by $0.04, beats on revenue
[11/5/2020 7:08 AM]
21.34 0.60 
(2.89%)
21.34 0.0 
(0.00%)
6.25 - 21.72 2,607,476 2,228,011 21,582
10-08-2020 PM 7:00 AM ET
(Aug 10)
FOLD Amicus Therapeutics, Inc. 3,960 -0.20 -0.26 -0.34 Amicus Therapeutics EPS beats by $0.07, beats on revenue
[8/10/2020 7:07 AM]
15.22 -0.19 
(-1.23%)
15.35 -0.06 
(-0.39%)
6.25 - 16.13 632,446 2,065,793 15,770